Histone deacetylases function as novel potential therapeutic targets for cancer

H Zhang, YP Shang, H Chen, J Li - Hepatology Research, 2017 - Wiley Online Library
Diverse cellular functions, including tumor suppressor gene expression, DNA repair, cell
proliferation and apoptosis, are regulated by histone acetylation and deacetylation. Histone …

[HTML][HTML] Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications

Z Li, WG Zhu - International journal of biological sciences, 2014 - ncbi.nlm.nih.gov
Genetic abnormalities have been conventionally considered as hallmarks of cancer.
However, studies over the past decades have demonstrated that epigenetic regulation also …

[HTML][HTML] The role of histone deacetylases (HDACs) in human cancer

S Ropero, M Esteller - Molecular oncology, 2007 - Elsevier
The balance of histone acetylation and deacetylation is an epigenetic layer with a critical
role in the regulation of gene expression. Histone acetylation induced by histone acetyl …

Histone deacetylase inhibitors: biology and mechanism of action

JM Mehnert, WK Kelly - The Cancer Journal, 2007 - journals.lww.com
Histone deacetylases (HDACs) and histone acetyltransferases are enzymes that regulate
chromatin structure and function through the removal and addition, respectively, of the acetyl …

Histone deacetylase inhibitors: apoptotic effects and clinical implications

S Emanuele, M Lauricella… - … journal of oncology, 2008 - spandidos-publications.com
It has been shown that epigenetic modifications play an important role in tumorigenesis.
Thus, affecting epigenetic tumorigenic alterations can represent a promising strategy for …

Histone deacetylases and cancer: causes and therapies

PA Marks, RA Rifkind, VM Richon, R Breslow… - Nature Reviews …, 2001 - nature.com
Together, histone acetyltransferases and histone deacetylases (HDACs) determine the
acetylation status of histones. This acetylation affects the regulation of gene expression, and …

Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer

O Martínez-Iglesias, L Ruiz-Llorente… - Clinical and …, 2008 - Springer
Histone deacetylases (HDACs) remove the acetyl groups of lysine residues of histone tails
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …

Histone deacetylase inhibitors–molecular mechanisms of actions and clinical applications

A Grabarska, M Dmoszyńska-Graniczka… - Advances in Hygiene …, 2013 - phmd.pl
Histone deacetylases (HDACs) play an important role in the epigenetic regulation of gene
expression implicated in cancer pathogenesis. Inhibitors of HDACs (HDI) are under …

Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective

KV Balakin, YA Ivanenkov, AS Kiselyov… - Anti-Cancer Agents …, 2007 - ingentaconnect.com
Regulation of gene expression is mediated by several mechanisms such as DNA
methylation, ATP-dependent chromatin remodeling, and post-translational modifications of …

Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents

DH Kim, MJ Kim, HJ Kwon - BMB Reports, 2003 - koreascience.kr
The acetylation state of histone is reversibly regulated by histone acetyltransferase (HAT)
and deacetylase (HDAC). An imbalance of this reaction leads to an aberrant behavior of the …